Instrument/analyser IVDs

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Commercializzato da:

Martin Flynn PTY LTD

Classe:

Class 1

Prodotto da:

DRG International Inc 841 Mountain Avenue, Springfield, NJ, 07081 United States Of America

Area terapeutica:

CT943 - Instrument/analyser IVDs

Indicazioni terapeutiche:

HYB-5252 -GMDN 56718/62413 - The DRG:HYBRiD-XL? was developed for the use in Laboratories, Institutions and Doctors Practices. The DRG:HYBRID-XL? is capable of processing a broad variety of Clinical Chemistry and immunoassay. The DRG:HYBRiD-XL? is a random-access analyzer intended for professional use and must only be used by trained personnel working in compliance with the precautions for use set out in this manual and good laboratory practice (GLP).

Stato dell'autorizzazione:

A

Data dell'autorizzazione:

2020-02-13